Alternatives to Basepaws

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Developing novel therapies to reverse aging and extend lifespan.

Developing advanced crop genetics for higher yields and sustainability in agriculture.

Scalable, one-time curative in-vivo gene editing therapies.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

A de-extinction biotechnology company aiming to revive extinct species.

Digital pathology imaging technology and AI-driven precision pathology software.

WEKA is a data platform for AI and HPC workloads, delivering extreme performance for GPU clusters, genomics pipelines, and data-intensive applications.

Leveraging the adaptive immune system to diagnose and treat disease.

Global life sciences company providing diagnostic and biopharma laboratory services.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Unleashing the power of genomics at scale for biological advances and human health.

Develops a computational model of the human body for drug discovery and development.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered spatial biology platform for precision medicine and drug development.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing climate-resilient crop varieties using gene editing for sustainable agriculture.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for designing novel molecular structures for new medicines.

Personalized health and performance insights based on blood biomarkers and DNA.

Mapping cell-cell communication at scale in human tissue.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Personalized genetic insights for health, ancestry, and wellness.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Tech-enabled veterinary care provider bringing comprehensive pet care to the comfort of your home.

Consumer genomics platform for health insights and predictions.

Life science company pioneering drug discovery with AI and advanced technologies.

Lucis transforms blood tests into actionable health insights for a healthier, longer life.

Advanced infectious disease diagnostics

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Global healthcare solutions company providing at-home health testing, telehealth, and pharmacy services.

A biotechnology company developing genetic therapies for rare disorders.

Equinom is a food-tech company developing delicious, nutritious, affordable, and sustainable non-GMO plant-based ingredients.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.